1. Кулешова Э.В., Казенов П.А., Лоховинина Н.Л. и др. Влияние операции коронарного шунтирования на ишемию миокарда (по данным холтеровского мониторирования. Вест аритм 2000; 20: 44-8.
2. Bishop J, Kirnan L, Butt R. Mechanical load enhances the stimulating effect of angiotensin II on human cardiac fibroblast procollagen synthesis. Circulation 1996; 94: 1657-61.
3. Borlan J, Chester A, Crabbe S, et al. Differential action of angiotensin II and activity of angiotensin-convertising enzyme in human bypass grafts. J Thorac Cardiovasc Surg 1998; 116: 206-12.
4. Calo L, Bianconi L, Collivicchi F, et al. Рrevention of atrial fibrillation by n-3 polyunsaturated fatty acids after coronary artery bypass grafting. JACC 2005; 45: 1723-8.
5. Саrlson M, Waynelson O. Five-year results after coronary bypass surgery. N Engl J Med 2003; 348: 1456-63.
6. Eagle K, Guyton R, Davidoff R, et al. ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery. AHA - www.americanheart.org
7. Goldman S, Copeland J, Moritz T. Internal mammary artery and safenous vein graft patency: effects of aspirin. Circulation 1990; 82(Suppl IV): 273, 42.
8. Harris W, Reid K, Sands S, Spertus J. Red blood cell omega- 3 fatty acids in acute coronary syndrome patients. Circulation 2007; 115(8): P267.
9. Belperio J, Keane M, Arenberg D, et al. CXC chemokines in angiogenesis. J Leukoc Biology 2000; 68:123-6.
10. Knoller-Hansen L, Steffesnsen R, Grande P. The Angiotensin-converting Enzyme Inhibition PostRevascularization Study (APRES). JACC 2000; 35: 8881-8.
11. Lorenz R, Schacky C, Weber M. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily): effects on platelet aggregation and tromboxane formation. Lancet 1984; 1: 1261-4.
12. Mori T, Beilin L. Omega-3 fatty acids and inflammation. Curr Atheroscl Rep 2004; 6 (6): 461-7.
13. Ommen S, Odell J, Stanton M. Atrial arrhytmias after cardiothoracic surgery. N Engl J Med 1997; 336: 1429-34.
14. Oosterga M, Voors A, Pinto V, et al. Effects of quinapril on clinical outcome after coronary bypass grafting (the QUOVADIS study). JACC 2001; 87: 542-6.
15. Predel H, Yang Z, von Segesser L, et al. Implications of pulsatile stretch on growth of saphenous vein and mammary artery smooth muscle. Lancet 1992; 340: 878-82.
16. Reape J, Groot H. Chemokines and inflammation. Atherosclerosis 1999; 147: 213-25.
17. Sethi G, Copeland J, Goldman S, et al. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting: Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy. JACC 1990; 15: 15-20.
18. Sheikine Y, Hansson G. Chemokines and atherosclerosis. Ann Med 2004; 36: 98-118.
19. Wang J, Su S, Gong W, Oppenheim J. Chemokines, receptors and their role in cardiovascular pathology. Int J Clin Lab Res 1998; 28: 83-90.
20. Yokoyama M, Suma H, Takeuchi A, et al. Fish oil bolsters statin reduction of coronary events. Lancet 2007; 369: 1090-8.